Search research articles
Contact Us
Filters
Showing results (231-240 of 279) with videos related to
Page
of 28
Sort By:
Science Advances
|
March 14, 2025
The oral drug obeldesivir protects nonhuman primates against lethal Ebola virus infection
Courtney Woolsey, Robert W Cross, Victor C Chu, et al.
Journal of Virology
|
February 4, 2021
Prominent Neutralizing Antibody Response Targeting the <i>Ebolavirus</i> Glycoprotein Subunit Interface Elicited by Immunization
Yimeng Wang, Katie A Howell, Jennifer Brannan, et al.
Antiviral Research
|
December 3, 2016
Assessment of the potential for host-targeted iminosugars UV-4 and UV-5 activity against filovirus infections in vitro and in vivo
Kelly L Warfield, Travis K Warren, Xiangguo Qiu, et al.
Pathogens (Basel, Switzerland)
|
June 24, 2022
Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus Immunotherapeutic
Erin Kuang, Robert W Cross, Maria McCavitt-Malvido, et al.
Emerging Microbes & Infections
|
August 6, 2025
Experimental challenge of African green monkeys with contemporary Hendra virus isolates produces divergent clinical disease
Declan D Pigeaud, Karla A Fenton, Jacquelyn Turcinovic, et al.
Biorxiv : the Preprint Server for Biology
|
June 22, 2026
Finding the Goldilocks zone: Modulating glycoprotein cleavage and fusogenicity optimizes the efficacy of a candidate Crimean-Congo hemorrhagic fever virus vaccine
Jacob Berrigan, Stephanie R Monticelli, Pieter Spealman, et al.
Cell Reports
|
September 1, 2021
Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein
Michael P Doyle, Nurgun Kose, Viktoriya Borisevich, et al.
Science Translational Medicine
|
December 14, 2022
A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates
Ruth Hunegnaw, Anna N Honko, Lingshu Wang, et al.
Plos One
|
February 21, 2018
A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates
Benoit Callendret, Jort Vellinga, Kerstin Wunderlich, et al.
Plos One
|
April 25, 2018
Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates
Benoit Callendret, Jort Vellinga, Kerstin Wunderlich, et al.
Page
of 28
Search research articles
Search
Showing results (231-240 of 279) with videos related to
Sort By:
Page
of 28
Science Advances
|
March 14, 2025
The oral drug obeldesivir protects nonhuman primates against lethal Ebola virus infection
Courtney Woolsey, Robert W Cross, Victor C Chu, et al.
Journal of Virology
|
February 4, 2021
Prominent Neutralizing Antibody Response Targeting the <i>Ebolavirus</i> Glycoprotein Subunit Interface Elicited by Immunization
Yimeng Wang, Katie A Howell, Jennifer Brannan, et al.
Antiviral Research
|
December 3, 2016
Assessment of the potential for host-targeted iminosugars UV-4 and UV-5 activity against filovirus infections in vitro and in vivo
Kelly L Warfield, Travis K Warren, Xiangguo Qiu, et al.
Pathogens (Basel, Switzerland)
|
June 24, 2022
Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus Immunotherapeutic
Erin Kuang, Robert W Cross, Maria McCavitt-Malvido, et al.
Emerging Microbes & Infections
|
August 6, 2025
Experimental challenge of African green monkeys with contemporary Hendra virus isolates produces divergent clinical disease
Declan D Pigeaud, Karla A Fenton, Jacquelyn Turcinovic, et al.
Biorxiv : the Preprint Server for Biology
|
June 22, 2026
Finding the Goldilocks zone: Modulating glycoprotein cleavage and fusogenicity optimizes the efficacy of a candidate Crimean-Congo hemorrhagic fever virus vaccine
Jacob Berrigan, Stephanie R Monticelli, Pieter Spealman, et al.
Cell Reports
|
September 1, 2021
Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein
Michael P Doyle, Nurgun Kose, Viktoriya Borisevich, et al.
Science Translational Medicine
|
December 14, 2022
A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates
Ruth Hunegnaw, Anna N Honko, Lingshu Wang, et al.
Plos One
|
February 21, 2018
A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates
Benoit Callendret, Jort Vellinga, Kerstin Wunderlich, et al.
Plos One
|
April 25, 2018
Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates
Benoit Callendret, Jort Vellinga, Kerstin Wunderlich, et al.
Page
of 28